Top 5 High Tech Stocks To Buy Right Now

The fact that gaming is no longer just gaming continues to benefit esports stocks. Esports, or competitions centered on video gaming, has reached new heights in popularity. Since Activision (NASDAQ:ATVI) created its Overwatch League for competitive gaming, esports have increased in popularity.

Over 360 million watched streamed video of the League of Legends competition. Since then, Arlington, Texas — already home to both the Dallas Cowboys and the Texas Rangers — will construct another sporting facility as it builds the largest arena in the country dedicated to esports. Further, the International Olympic Committee (IOC) may approve esports as a competition starting with the 2024 Olympic Games.

Such a trend affects stocks across the tech landscape. Not only are gaming companies helped, other firms also derive a considerable benefit. Many point to the stocks that dominate American video gaming, namely Activision, Electronic Arts (NASDAQ:EA), and Take-Two Interactive (NASDAQ:TTWO) as obvious winners.

Top 5 High Tech Stocks To Buy Right Now: Western Asset Mortgage Capital Corporation(WMC)

Advisors’ Opinion:

  • [By Max Byerly]

    ValuEngine lowered shares of Western Asset Mortgage Capit (NYSE:WMC) from a buy rating to a hold rating in a research report report published on Wednesday.

  • [By Stephan Byrd]

    Lincoln National Corp acquired a new position in Western Asset Mortgage Capital Corp (NYSE:WMC) during the 2nd quarter, Holdings Channel reports. The fund acquired 11,000 shares of the financial services provider’s stock, valued at approximately $115,000.

Top 5 High Tech Stocks To Buy Right Now: Virtusa Corporation(VRTU)

Advisors’ Opinion:

  • [By Lisa Levin]

    Virtusa Corporation (NASDAQ: VRTU) is projected to report quarterly earnings at $0.55 per share on revenue of $279.85 million.

    Kamada Ltd. (NASDAQ: KMDA) is expected to report quarterly earnings at $0.02 per share on revenue of $24.02 million.

  • [By Max Byerly]

    Virtusa (NASDAQ:VRTU) – Equities research analysts at SunTrust Banks issued their Q1 2020 earnings per share (EPS) estimates for shares of Virtusa in a report released on Wednesday, May 16th. SunTrust Banks analyst F. Atkins expects that the information technology services provider will post earnings of $0.33 per share for the quarter. SunTrust Banks currently has a “Hold” rating on the stock. SunTrust Banks also issued estimates for Virtusa’s Q2 2020 earnings at $0.46 EPS, Q3 2020 earnings at $0.56 EPS and Q4 2020 earnings at $0.60 EPS.

  • [By Max Byerly]

    Sei Investments Co. reduced its stake in Virtusa Co. (NASDAQ:VRTU) by 5.5% during the 1st quarter, HoldingsChannel reports. The fund owned 21,835 shares of the information technology services provider’s stock after selling 1,275 shares during the period. Sei Investments Co.’s holdings in Virtusa were worth $1,058,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Great Lakes Advisors LLC grew its holdings in shares of Virtusa (NASDAQ:VRTU) by 38.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 166,531 shares of the information technology services provider’s stock after buying an additional 45,860 shares during the quarter. Great Lakes Advisors LLC owned 0.57% of Virtusa worth $8,070,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Virtusa (NASDAQ:VRTU) had its target price lifted by equities research analysts at Wedbush from $60.00 to $70.00 in a research report issued to clients and investors on Friday. The brokerage currently has an “outperform” rating on the information technology services provider’s stock. Wedbush’s price target suggests a potential upside of 23.09% from the company’s current price.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Virtusa (VRTU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 High Tech Stocks To Buy Right Now: Walker & Dunlop, Inc.(WD)

Advisors’ Opinion:

  • [By Keith Speights]

    Gilead Sciences (NASDAQ:GILD), Micron Technology (NASDAQ:MU), and Walker & Dunlop (NYSE:WD) actually have relatively low valuations. Here’s why these are three bargain stocks you can buy right now. 

  • [By Stephan Byrd]

    Walker & Dunlop (NYSE: WD) and Medallion Financial (NASDAQ:MFIN) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, profitability, risk, earnings, institutional ownership, analyst recommendations and dividends.

  • [By Stephan Byrd]

    Walker & Dunlop, Inc. (NYSE:WD) shares were down 5.2% during mid-day trading on Wednesday after the company announced weaker than expected quarterly earnings. The company traded as low as $52.74 and last traded at $56.18. Approximately 824,229 shares changed hands during mid-day trading, an increase of 265% from the average daily volume of 225,646 shares. The stock had previously closed at $59.26.

  • [By Ethan Ryder]

    Rhumbline Advisers lifted its holdings in Walker & Dunlop (NYSE:WD) by 1.5% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 66,236 shares of the financial services provider’s stock after purchasing an additional 961 shares during the period. Rhumbline Advisers owned approximately 0.22% of Walker & Dunlop worth $3,936,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Boston Partners increased its holdings in Walker & Dunlop, Inc. (NYSE:WD) by 3.1% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,495,943 shares of the financial services provider’s stock after buying an additional 45,657 shares during the period. Boston Partners owned about 4.82% of Walker & Dunlop worth $83,249,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Stephan Byrd]

    Assetmark Inc. boosted its holdings in Walker & Dunlop, Inc. (NYSE:WD) by 40,411.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,646 shares of the financial services provider’s stock after buying an additional 3,637 shares during the period. Assetmark Inc.’s holdings in Walker & Dunlop were worth $217,000 as of its most recent SEC filing.

Top 5 High Tech Stocks To Buy Right Now: FIRST REPUBLIC BANK(FRC)

Advisors’ Opinion:

  • [By Logan Wallace]

    Barclays (NYSE:BCS) and First Republic Bank (NYSE:FRC) are both large-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, risk, earnings, dividends, valuation, profitability and analyst recommendations.

  • [By Motley Fool Transcription]

    First Republic Bank (NYSE:FRC)Q3 2018 Earnings Conference CallOct. 12, 2018, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Motley Fool Staff]

    First Republic Bank (NYSE:FRC) Q1 2018 Earnings Conference CallApril 13, 2018 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 5 High Tech Stocks To Buy Right Now: Lexicon Pharmaceuticals, Inc.(LXRX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Lexicon Pharmaceuticals (LXRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Todd Campbell]

    Sanofi’s also awaiting an FDA decision on sotagliflozin, a drug it licensed from Lexicon Pharmaceuticals (NASDAQ:LXRX) in 2015 for $300 million up front, up to $430 million in development and regulatory milestones, up to $990 million in specified sales milestones, and tiered, escalating royalties ranging from low double-digit percentages to 40% of net sales. 

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday.
    Akers Biosciences, Inc. (NASDAQ: AKER) jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Kitov Pharma Ltd (NASDAQ: KTOV) gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 28.21 percent to close at $19.86.
    J.Jill, Inc. (NYSE: JILL) climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings.
    Curis, Inc. (NASDAQ: CRIS) shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory.
    Boxlight Corporation (NASDAQ: BOXL) gained 21.23 percent to close at $7.48.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results.
    The Brink's Company (NYSE: BCO) jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Applied Optoelectronics, Inc. (NASDAQ: AAOI) rose 15.14 percent to c

Leave a Reply

Your email address will not be published. Required fields are marked *